Ieq Capital LLC Acquires 1,891 Shares of Unilever PLC (NYSE:UL)

Ieq Capital LLC raised its holdings in Unilever PLC (NYSE:UL) by 15.7% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 13,946 shares of the company’s stock after purchasing an additional 1,891 shares during the quarter. Ieq Capital LLC’s holdings in Unilever were worth $791,000 as of its most recent SEC filing.

Other institutional investors have also recently bought and sold shares of the company. Fisher Asset Management LLC raised its position in shares of Unilever by 7.1% during the third quarter. Fisher Asset Management LLC now owns 16,726,400 shares of the company’s stock worth $1,086,547,000 after acquiring an additional 1,114,177 shares during the last quarter. Jennison Associates LLC raised its position in shares of Unilever by 66.4% during the fourth quarter. Jennison Associates LLC now owns 3,454,686 shares of the company’s stock worth $195,881,000 after acquiring an additional 1,378,517 shares during the last quarter. Hamlin Capital Management LLC raised its position in shares of Unilever by 7.8% during the fourth quarter. Hamlin Capital Management LLC now owns 2,874,929 shares of the company’s stock worth $163,008,000 after acquiring an additional 207,549 shares during the last quarter. Bank of Montreal Can raised its position in shares of Unilever by 3.7% during the third quarter. Bank of Montreal Can now owns 1,812,164 shares of the company’s stock worth $118,588,000 after acquiring an additional 63,835 shares during the last quarter. Finally, Allspring Global Investments Holdings LLC raised its position in shares of Unilever by 18.2% during the fourth quarter. Allspring Global Investments Holdings LLC now owns 1,240,653 shares of the company’s stock worth $70,132,000 after acquiring an additional 190,753 shares during the last quarter. Institutional investors own 9.67% of the company’s stock.

Unilever Trading Down 0.8 %

NYSE:UL opened at $55.87 on Wednesday. Unilever PLC has a 52-week low of $46.46 and a 52-week high of $65.87. The stock has a 50-day simple moving average of $56.66 and a 200 day simple moving average of $60.01.

Unilever Cuts Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, March 28th. Investors of record on Friday, February 28th will be issued a dividend of $0.4674 per share. The ex-dividend date is Friday, February 28th. This represents a $1.87 dividend on an annualized basis and a dividend yield of 3.35%.

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on the company. StockNews.com downgraded Unilever from a “buy” rating to a “hold” rating in a research report on Wednesday. DZ Bank raised Unilever from a “hold” rating to a “buy” rating in a research note on Friday, February 21st. Erste Group Bank reaffirmed a “hold” rating on shares of Unilever in a research note on Tuesday, November 19th. Sanford C. Bernstein raised Unilever from a “hold” rating to a “strong-buy” rating in a research note on Thursday, January 9th. Finally, Royal Bank of Canada cut Unilever from a “sector perform” rating to an “underperform” rating in a research note on Monday, January 6th. Three research analysts have rated the stock with a sell rating, two have assigned a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $61.75.

Unilever Profile

Unilever PLC operates as a fast-moving consumer goods company in the Asia Pacific, Africa, the Americas, and Europe. It operates through five segments: Beauty & Wellbeing, Personal Care, Home Care, Nutrition, and Ice Cream. The Beauty & Wellbeing segment engages in the sale of hair care products, such as shampoo, conditioner, and styling; skin care products including face, hand, and body moisturizer; and prestige beauty and health & wellbeing products consist of the vitamins, minerals, and supplements.